1. Home
  2. OPBK vs VYGR Comparison

OPBK vs VYGR Comparison

Compare OPBK & VYGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo OP Bancorp

OPBK

OP Bancorp

HOLD

Current Price

$14.74

Market Cap

213.9M

Sector

Finance

ML Signal

HOLD

Logo Voyager Therapeutics Inc.

VYGR

Voyager Therapeutics Inc.

HOLD

Current Price

$3.47

Market Cap

203.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OPBK
VYGR
Founded
2005
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
213.9M
203.6M
IPO Year
2018
2015

Fundamental Metrics

Financial Performance
Metric
OPBK
VYGR
Price
$14.74
$3.47
Analyst Decision
Buy
Strong Buy
Analyst Count
2
2
Target Price
$16.50
$16.50
AVG Volume (30 Days)
57.8K
701.2K
Earning Date
04-23-2026
05-08-2026
Dividend Yield
3.73%
N/A
EPS Growth
23.74
N/A
EPS
0.48
N/A
Revenue
$3,204,000.00
$10,135,000.00
Revenue This Year
$16.07
$34.04
Revenue Next Year
$11.60
$7.92
P/E Ratio
$30.56
N/A
Revenue Growth
N/A
N/A
52 Week Low
$12.41
$2.88
52 Week High
$15.73
$5.55

Technical Indicators

Market Signals
Indicator
OPBK
VYGR
Relative Strength Index (RSI) 52.85 43.22
Support Level $13.68 $3.33
Resistance Level $15.07 $4.33
Average True Range (ATR) 0.42 0.18
MACD -0.04 0.01
Stochastic Oscillator 40.12 12.24

Price Performance

Historical Comparison
OPBK
VYGR

About OPBK OP Bancorp

OP Bancorp operates its commercial community banking activities through Open Bank its wholly owned banking subsidiary. It provides commercial banking services to small and medium-sized businesses, their owners, and retail customers, with a focus on the Korean-American community. The bank currently operate twelve full service branches: nine branches across Los Angeles and Orange Counties in California, as well as one branch each in Santa Clara, California; Carrollton, Texas; and Las Vegas, Nevada. Additionally, it maintains five loan production offices located in Pleasanton, California; Atlanta, Georgia; Aurora, Colorado; Lynnwood, Washington; and Fairfax, Virginia. Substantially all its business activities are conducted through the Bank.

About VYGR Voyager Therapeutics Inc.

Voyager Therapeutics Inc is a biotechnology company to leverage the power of human genetics to modify the course of and ultimately cure neurological diseases. Its pipeline includes programs for Alzheimer's disease, or AD; Friedreich's ataxia, or FA; Parkinson's disease, or PD; and multiple other diseases of the central nervous system, or CNS. Many of its programs are derived from its TRACER (Tropism Redirection of AAV by Cell-type-specific Expression of RNA) adeno-associated virus, or AAV, capsid discovery platform, which the company has used to generate novel capsids, or TRACER Capsids, and identify associated receptors to potentially enable high brain penetration with genetic medicines following intravenous, or IV, dosing. Its segment is developing and commercializing genetic medicine.

Share on Social Networks: